Home › NDC Lookup › RxCUI directory › RxCUI 1596108

Acetaminophen 320.5 MG / caffeine 30 MG / dihydrocodeine bitartrate 16 MG Oral Capsule — RxCUI 1596108

RxNorm drug concept · Semantic clinical drug
RxCUI 1596108 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1596108
Official nameAcetaminophen 320.5 MG / caffeine 30 MG / dihydrocodeine bitartrate 16 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asAPAP 320.5 MG / Caffeine 30 MG / dihydrocodeine bitartrate 16 MG Oral Capsule
FDA products mapped1
Package NDCs mapped5
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Acetaminophen Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Great question. The IV form is used when you can't take medication by mouth — for example, after surgery, if you're nauseated, or if you need faster, more reliable absorption. It d...
  • Why am I getting acetaminophen through an IV instead of just taking a pill?
  • Yes, Acetaminophen Injection is approved for children — for pain relief in kids 2 years and older, and for fever reduction in patients of all ages, including premature newborns bor...
  • The most important things to watch for are signs of a serious allergic reaction — swelling of your face, mouth, or throat, trouble breathing, or hives — and any new skin rash. Eith...
📖 Read our full Acetaminophen Injection guide →

🕸️ Concept Web — How Acetaminophen 320.5 MG / caffeine 30 MG / dihydr... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Acetaminophen 320.5 MG / caffeine 30 MG / dihydrocodeine bitartrate 16 MG Oral Capsule RxCUI 1596108

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 5

    The active substance itself — no strength, form, or brand attached yet.

    • Acetaminophen 161
    • Caffeine 1886
    • Dihydrocodeine 23088
    • Acetaminophen / caffeine / dihydrocodeine 689569
    • Dihydrocodeine bitartrate 104966
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Trezix 746611
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Acetaminophen / caffeine / dihydrocodeine Oral Capsule 374787
    • Acetaminophen / caffeine / dihydrocodeine bitartrate Oral Capsule 2646120
    • Acetaminophen / caffeine / dihydrocodeine Oral Product 1154590
    • Acetaminophen / caffeine / dihydrocodeine Pill 1154591
    • Acetaminophen / caffeine / dihydrocodeine bitartrate Oral Product 2663452
    • Acetaminophen / caffeine / dihydrocodeine bitartrate Pill 2659189
    • Acetaminophen / caffeine / dihydrocodeine Oral Capsule [Trezix] 746613
    • Acetaminophen / caffeine / dihydrocodeine bitartrate Oral Capsule [Trezix] 2654661
    • +5 more in this family
  4. Clinical & branded drugs 5

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 19 of 24 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Acetaminophen 320.5 MG SCDC · 1596107
  • Caffeine 30 MG SCDC · 315509
  • Dihydrocodeine bitartrate 16 MG SCDC · 1190194
  • Acetaminophen / caffeine / dihydrocodeine Oral Capsule SCDF · 374787
  • Acetaminophen / caffeine / dihydrocodeine bitartrate Oral Capsule SCDFP · 2646120
  • Acetaminophen / caffeine / dihydrocodeine Oral Product SCDG · 1154590
  • Acetaminophen / caffeine / dihydrocodeine Pill SCDG · 1154591
  • Acetaminophen / caffeine / dihydrocodeine bitartrate Oral Product SCDGP · 2663452
  • Acetaminophen / caffeine / dihydrocodeine bitartrate Pill SCDGP · 2659189

Brand-Name Concepts

📦 FDA Products & Package NDCs

1 product · 5 package NDCs
5 package NDCs map to RxCUI 1596108 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
63187-0705-00 100 CAPSULE in 1 BOTTLE (63187-705-00) Trezix Proficient Rx LP 2016-06-01
63187-0705-30 30 CAPSULE in 1 BOTTLE (63187-705-30) Trezix Proficient Rx LP 2016-06-01
63187-0705-60 60 CAPSULE in 1 BOTTLE (63187-705-60) Trezix Proficient Rx LP 2016-06-01
63187-0705-72 120 CAPSULE in 1 BOTTLE (63187-705-72) Trezix Proficient Rx LP 2018-08-01
63187-0705-90 90 CAPSULE in 1 BOTTLE (63187-705-90) Trezix Proficient Rx LP 2016-06-01
Observed labelers: Proficient Rx LP (5) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.